Marcus M. Reidenberg, M.D., F.A.C.P.

Professor of Pharmacology, Medicine, and Public Health
Assistant Dean, Weill Cornell Medical College
Attending Physician, NewYork-Presbyterian Hospital

Selected Recent Publications

Jung B, Reidenberg MM. Deceiving physicians. Pain Medicine in press.

Reidenberg MM, Willis O. Prosecution of physicians for prescribing opioids to patients. Clin Pharmacol Ther 2007 Jun;81(6):903-906.

Reidenberg MM. Improving how we evaluate the toxicity of approved drugs. Clin Pharmacol Ther 2006; 80: 1-6.

Reidenberg MM. We should not say "drug safety" when we mean drug toxicity." WHO Pharmaceuticals Newsletter 2006; No. 2, 7-8.

Jung B, Reidenberg MM. The risk of action by the DEA against physicians prescribing opioids for pain. Pain Medicine 2006; 7:353-357.

Reidenberg MM. Improving how we evaluate the toxicity of approved drugs. Clin Pharmacol Ther 2006; 80: 1-6.

Jung BF, Reidenberg MM. Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies. Clin Pharmacol Ther 2005; 77:324-34.

Richard J, Reidenberg MM. The risk of disciplinary action by state medical boards against physicians prescribing opioids. J Pain & Symptom Mgt, 2005, 29:206-212.

Reidenberg MM. Informed consent or acknowledgment or disclosure. Clin Pharmacol Ther 2005; 78:439-440.

Reidenberg MM. Conflict of interest and medical publication. Science and Engineering Ethics 2002; 8:455-7.

Reidenberg, MM, Reidenberg, JR: Who Should Have Access to the Research Data? Clin Pharmacol Ther, 2002; 71:309-310.

Marcus M. Reidenberg Marcus M. Reidenberg, M.D., F.A.C.P.
Top of page